MedTrace Logo

DaxibotulinimtoxinA for Treatment of Platysmal Neck Bands

NCT06225492 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-03-19

No results posted yet for this study

Summary

This study seeks to evaluate the effectiveness and duration of action of DaxibotulinumtoxinA for neck rejuvenation through treatment of platysmal bands. This study will consist of one treatment visit with subjects being randomized to receiving 15 or 20 units of DaxibotulinumtoxinA per platysmal band. Subjects will return for 5 follow-up visits at 8, 12, 16, 20, and 24 weeks for evaluation.

Conditions

  • Aging

Interventions

DRUG

DaxibotulinumtoxinA 15 units

Subjects will be treated with 15 units of daxibotulinumtoxinA per platysmal band

DRUG

DaxibotulinumtoxinA 20 units

Subjects will be treated with 20 units of daxibotulinumtoxinA per platysmal band

Sponsors & Collaborators

  • Main Line Center for Laser Surgery

    lead OTHER

Principal Investigators

  • Kachiu Lee, MD · Physician

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
31 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-01-01
Completion
2025-01-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06225492 on ClinicalTrials.gov